Boston Scientific is an innovator of medical solutions that improve patient health.
Boston Scientific is an innovator of medical solutions that improve the health of patients around the world. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies, and services across a wide range of medical specialties. These less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems. Boston Scientific continues to innovate in these areas and is extending its innovations into new geographies and high-growth adjacency markets. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific acts with integrity and compassion to support patients, customers, our communities, and each other.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 4, 2022 | Post-IPO Debt | €3B | — | — | — | Detail |
May 21, 2020 | Post-IPO Equity | $2B | — | — | — | Detail |
Feb 27, 2018 | Post-IPO Debt | $1B | — | — | — | Detail |
May 29, 1992 | IPO | — | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 19, 2023
SetPoint Medical
|
Series Unknown | $80M | Biotechnology | — |
Dec 8, 2022
Shibuya
|
Seed | $6.90M | Blockchain | — |
Jun 9, 2022
Request Finance
|
Seed | $5.50M | Accounting | — |
Mar 17, 2022
LAGO
|
Pre-seed | $4.20M | Art | — |
Feb 8, 2022
Rift Finance
|
Series Unknown | $18M | Blockchain | — |
Boston Scientific has had 18 exits. Boston Scientific most notable exits include Broncus Technologies , RenovoRx
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Sep 24, 2021 | Broncus Technologies | IPO | Biotechnology | Detail |
Aug 25, 2021 | RenovoRx | IPO | Biotechnology | Detail |
Jan 21, 2021 | Preventice Solutions | M&A | Health Care | Detail |
Sep 30, 2020 | Pulmonx | IPO | Health Care | Detail |
Jul 9, 2018 | TVA Medical | M&A | Health Care | Detail |
Boston Scientific has acquired 54 organizations. Their most recent acquisition was Boston Scientific Scimed on Nov 9, 1994. They acquired Boston Scientific Scimed for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Nov 9, 1994
Boston Scientific Scimed
|
Health Care | acquisition | — | Detail |
Jan 22, 1996
EP Technologies
|
Health Care | acquisition | — | Detail |
Jan 21, 1997
Target Therapeutics
|
Fitness | acquisition | — | Detail |
Feb 22, 2001
Embolic Protection
|
Health Care | acquisition | $ 75M | Detail |
Mar 1, 2001
Catheter Innovations
|
Health Care | acquisition | — | Detail |